Works by Kaibo Xu


Results: 15
    1
    2
    3

    A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif<sup>®</sup> in healthy Chinese subjects.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 6, p. 2585, doi. 10.1007/s00432-022-04148-1
    By:
    • Liu, Guangwen;
    • Xue, Jinling;
    • Wang, Yanli;
    • Liu, Zhengzhi;
    • Li, Xue;
    • Qu, Dongmei;
    • Su, Zhengjie;
    • Xu, Kaibo;
    • Qu, Xinyao;
    • Qu, Zhaojuan;
    • Sun, Linlin;
    • Cao, Mingming;
    • Wang, Ying;
    • Chen, Xuesong;
    • Yu, Jing;
    • Liu, Lang;
    • Deng, Qiaohuan;
    • Zhao, Yicheng;
    • Zhang, Lixiu;
    • Yang, Haimiao
    Publication type:
    Article
    4
    5
    6

    A randomized, double-blind, single-dose, parallel phase I clinical trial to compare the bioequivalence, immunogenicity, and safety of bevacizumab biosimilar and bevacizumab in healthy Chinese subjects.

    Published in:
    Expert Opinion on Drug Metabolism & Toxicology, 2022, v. 18, n. 7/8, p. 519, doi. 10.1080/17425255.2022.2113382
    By:
    • Liu, Zhengzhi;
    • Gao, Zhenyue;
    • Yang, Wei;
    • Zhang, Lixiu;
    • Xiao, Nan;
    • Qu, Dongmei;
    • Su, Zhengjie;
    • Xu, Kaibo;
    • Liu, Guangwen;
    • Wang, Yanli;
    • Ren, Qing;
    • Yu, Shuang;
    • Cheng, Yang;
    • Zhou, Yannan;
    • Deng, Qiaohuan;
    • Zhao, Yicheng;
    • Wang, Zeyu;
    • Yang, Haimiao
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    A randomized, open-label, single-dose, two-cycle crossover study to evaluate the bioequivalence and safety of lenvatinib and Lenvima® in Chinese healthy subjects.

    Published in:
    Expert Opinion on Investigational Drugs, 2022, v. 31, n. 7, p. 737, doi. 10.1080/13543784.2022.2067528
    By:
    • Xu, Zhongnan;
    • Wang, Yanli;
    • Liu, Guangwen;
    • Chen, Jiahui;
    • Wang, Wanhua;
    • Cheng, Yang;
    • Ren, Qing;
    • Cui, Yingzi;
    • Yang, Wei;
    • Liu, Zhengzhi;
    • Chen, Xuesong;
    • Xue, Jinling;
    • Chang, Tianying;
    • Qu, Xinyao;
    • Yu, Shuang;
    • Zhou, Yannan;
    • Xu, Kaibo;
    • Su, Zhengjie;
    • Deng, Qiaohuan;
    • Zhao, Yicheng
    Publication type:
    Article
    15